IPCA Laboratories share news and announcements
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
Last close ₹1,953.30up ₹49.80 (2.62%)BSE ₹1,951.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,903.50.
52-week range of traded prices to 23 Oct 2026
₹1,251.60Low, 24 Oct 2025₹2,038.00High, 18 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹49,556 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 37.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 6.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,18,78151.9% delivered
IPCA Laboratories record dates, bonuses and splits
28 filed, newest first.
Jul 2026
14 Jul · Corporate action
Jul 2025
11 Jul · Corporate action
Nov 2024
Oct 2024
24 Oct · Corporate action
Jul 2024
Oct 2023
25 Oct · Corporate action
Nov 2022
11 Nov · Corporate action
2 Nov · Corporate action
Jul 2022
Dec 2021
24 Dec · Corporate action
Nov 2021
13 Nov · Corporate action
Oct 2021
20 Oct · Corporate action
Aug 2021
Nov 2020
7 Nov · Corporate action
Oct 2020
27 Oct · Corporate action
Aug 2020
Feb 2020
Jul 2018
Oct 2013
7 Oct · Corporate action
Company has fixed November 1, 2013 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2013-14 that may be declared at the Board Meeting to be held on October 24, 2013.
Oct 2012
9 Oct · Corporate action
Company has fixed November 02, 2012 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2012-13 that may be declared at the Board Meeting to be held on October 25, 2012. The dividend if declared shall be paid/ dispatched by November 23, 2012.
Jan 2012
17 Jan · Corporate action
Company has fixed February 08, 2012 as the 'Record Date' for the purpose of 2nd interim dividend for the financial year 2011-12. Further, the Divided Payment Date will be February 22, 2012.
Oct 2011
18 Oct · Corporate action
Company has fix November 07, 2011 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2011-12 that may be declared at the Board Meeting to be held on October 31, 2011.
Jan 2011
12 Jan · Corporate action
Company has fix February 02, 2011 as the 'Record Date' for the Members entitlement of 2nd interim dividend for the financial year 2010-11.
Oct 2010
7 Oct · Corporate action
Company has fix October 29, 2010 as the 'Record Date' for the entitlement of interim dividend for the financial year 2010-11.
Feb 2010
25 Feb · Corporate action
Ipca Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on February 25, 2010 have decided to fix March 23, 2010, as the 'Record Date' for the Members entitlement of sub-divided shares. Each fully paid-up equity share of Rs.10/- each of the Company is being sub-divided into 5 fully paid-up equity shares of Rs.2/- each.